Philadelphia, PA · Founded 2021 · Privately Held (backing)
Operator of a T-cell therapeutics company intended to offer a therapeutic pipeline targeting clinical needs in oncology and autoimmune disease. ViTToria Biotherapeutics is based in Philadelphia, PA and was founded in 2021. It was valued at $30 million at its early-stage round in Nov 2024, the last priced event on record. It has raised $49.9 million across 1 recorded round; the latest was an $8.7 million early-stage round in Jul 2021.
PMV mark · valuation
$30.0M
Oct 2026
Priced at
its early-stage round
Nov 2024
Total raised
$49.9M
Last round
Early Stage VC
Jul 2021
Cap table — not yet on record
ViTToria Biotherapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ViTToria Biotherapeutics with a free account
·The complete investor list: 15 names
·Watch ViTToria Biotherapeutics: the Monday email on marks, rounds and moves
Where does ViTToria Biotherapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ViTToria Biotherapeutics's 1 recorded funding rounds.
